After-Hours Movers 12/12: (SAM) (BBY) (CERN) Higher; (HRG) (ENDP) (JNPR) Lower (more...)

December 12, 2012 5:56 PM EST
Harbinger Group Inc. (NYSE: HRG) 17% LOWER; announced a registered secondary public offering of shares of its common stock by Harbinger Capital Partners Master Fund I, Ltd., Harbinger Capital Partners Special Situations Fund, L.P. and Global Opportunities Breakaway Ltd. The selling stockholders intend to grant the underwriters an option for 30 days to purchase additional shares. The Company will not sell any shares or receive any proceeds from the offering.

The Boston Beer Company, Inc. (NYSE: SAM) 12% HIGHER; expects its 2012 earnings per diluted share range to be between $4.30 and $4.60, an increase from the previously communicated range of $3.80 to $4.20 and the consensus of $4.21.

Endo Health Solutions Inc. (Nasdaq: ENDP) 5% LOWER; announced today David P. Holveck, 67, President and Chief Executive Officer, will retire in 2013. He will continue to serve in his present positions until the earlier of his successor being in place or the May 2013 annual meeting of Endo shareholders. Holveck will also leave the Board at such time

Best Buy Co., Inc. (NYSE: BBY) 4% HIGHER; ongoing speculation about a Schulze bid.

Juniper Networks, Inc. (NYSE: JNPR) 2% LOWER; entered into an acquisition agreement to acquire Contrail Networks Inc. in a cash and stock transaction for approximately $176 million.

Francesca's (Nasdaq: FRAN) 1% HIGHER; insider buying

Cerner Corporation (Nasdaq: CERN) 1% HIGHER; announced that its board of directors has approved a stock repurchase program, authorizing the repurchase of up to $170 million of its common stock. The company plans to repurchase shares from time to time in the open market, by block purchase, or possibly through other transactions managed by broker-dealers. No time limit was set for completion of the program.

Regal-Beloit Corp. (NYSE: RBC) 1% LOWER; has commenced a public offering of 2,750,000 shares of common stock. Regal Beloit will grant the underwriters in the offering an option to purchase up to 412,500 additional shares to cover any over-allotments.

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) 1% HIGHER; announced that it is offering to sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. Sarepta also intends to grant the underwriters a 30-day option to purchase from it up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if any.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

Harbinger Capital, After-Hours Movers, Stock Buyback, Earnings

Add Your Comment